EBMT 2023 Archives - Medical Conferences

Home > Haematology > EBMT 2023

Read the full Report (pdf)

European Group for Blood & Marrow Transplantation
23–26 April 2023 Paris, France

Featured articles

Letter from the Editor

Editor

Prof. Gert Ossenkoppele, Amsterdam UMC, the Netherlands

Conference

EBMT 2023

15 June 2023 13:27

EBMT 2023 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

EBMT 2023

14 May 2023 20:09

CAR T cells rise to the front in multiple myeloma

Expert

Dr Sergio Giralt, Memorial Sloan Kettering Cancer Center, USA

Trial

Phase 3, KarMMa-3

17 April 2023 12:45

Online First

Acute Leukaemia

Quizartinib plus chemotherapy improves OS in patients with AML undergoing ASCT

Presented By

Prof. Radovan Vrhovac, University Hospital Centre Zagreb, Croatia

Trial

Phase 3, QuANTUM-First

Conference

EMBT 2023

Type

Peer-reviewed article

14 June 2023 20:07

Blinatumomab may improve outcomes in patients with B-cell ALL undergoing ASCT

Presented By

Dr Ayman Sayyed, University of Toronto, Canada

Conference

EBMT 2023

Type

Peer-reviewed article

14 June 2023 20:02

Is ASCT a reasonable option in patients with invasive aspergillosis?

Presented By

Prof. Olaf Penack, Charité University Hospital of Berlin, Germany

Conference

EBMT 2023

Type

Peer-reviewed article

14 June 2023 19:55

Tacrolimus versus cyclosporin A in AML

Presented By

Dr Gesine Bug, Goethe University Frankfurt, Germany

Conference

EBMT 2023

Type

Peer-reviewed article

14 June 2023 19:48

Promising novel target identified for AML

Presented By

Prof. Edmund Waller, Emory University, GA, USA

Conference

EBMT 2023

Type

Peer-reviewed article

14 June 2023 19:42

Multiple Myeloma

Ide-cel superior to standard therapies in triple-class exposed RRMM

Presented By

Dr Paula Rodríguez-Otero, Clinica Universidad de Navarra, Spain

Trial

Phase 3, KarMMa-3

Conference

EBMT 2023

Type

Peer-reviewed article

15 June 2023 16:48

ASCT or CAR T cell as first-line therapy for MM?

Presented By

Prof. Salomon Manier, Lille University Hospital, France

Trial

Phase 3, CARTITUDE-6

Conference

EBMT 2023

Type

Peer-reviewed article

14 June 2023 20:23

DETERMINATION: Does one size fit all in multiple myeloma?

Presented By

Dr Hani Hassoun, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 3, DETERMINATION

Conference

EBMT 2023

Type

Peer-reviewed article

14 June 2023 20:14

Graft-Versus-Host Disease

New options to treat steroid-refractory chronic GvHD

Presented By

Prof. Mohamad Mohty, Sorbonne University, France

Conference

EBMT 2023

Type

Peer-reviewed article

15 June 2023 16:59

New developments in steroid-refractory acute GvHD

Presented By

Prof. Ronjon Chakraverty, University of Oxford, UK

Conference

EBMT 2023

Type

Peer-reviewed article

15 June 2023 16:54

Miscellaneous Topics

Long-term success for CD19 CAR T-cell therapy in CLL

Presented By

Dr Emily Liang, University of Washington, WA, USA

Trial

Phase 2

Conference

EBMT 2023

Type

Peer-reviewed article

15 June 2023 17:31

Can molecular data improve prognostication in MDS patients undergoing HSCT?

Presented By

Dr Carmelo Gurnari, Cleveland Clinic, OH, USA & Tor Vergata University, Italy

Conference

EMBT 2023

Type

Peer-reviewed article

15 June 2023 17:27

Next-generation cell therapies for cancer: CAR-NK cells

Presented By

Dr Katy Rezvani, MD Anderson Cancer Center, TX, USA

Conference

EBMT 2023

Type

Peer-reviewed article

15 June 2023 17:20

Novel drugs and strategies around ASCT for Hodgkin lymphoma

Presented By

Dr Anna Sureda, Catalan Institute of Oncology, Spain

Conference

EBMT 2023

Type

Peer-reviewed article

15 June 2023 17:15

Thalassaemia: Advances in conventional transplantation and gene therapy

Presented By

Prof. Josu de la Fuente, Imperial College London, UK

Conference

EBMT 2023

Type

Peer-reviewed article

15 June 2023 17:06

Featured articles

CONTENTS

Online First

Acute Leukaemia

Multiple Myeloma

Graft-Versus-Host Disease

Miscellaneous Topics